Putting Market Cap into Perspective
At $4.00 post split is actually only $.02 pre split. The company traded heavily at $.10 pre split, which would be $20.00 post split. Most pre-revenue medical device companies have market caps of around $30M, and upon revenues, starting near $80M. Right now, RXSF market cap is at $3.0M. $30M would put it at roughly $25.00 per share - so HOKIE is NOT that far off.
Now, consider about 30,000 shares of the real 180,000 public float has been taken out, and hopefully are being held by longs (late spring), that leaves roughly 150,000 now i the float.
